All In Biotech

Drug Trial Radar · NCT07715084

Study to Evaluate the Efficacy and Safety of Nizubaglustat (AZ-3102) in Patients With Gaucher Disease Type 3 (GD3)

96-week, Open-label, Phase 2 Study to Evaluate the Efficacy and Safety of Nizubaglustat (AZ-3102) in Patients With Gaucher Disease Type 3 (GD3)

Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

20

Planned (sponsor's estimate)

Start

Jan 25, 2027

Primary completion

Jan 2028

Study completion Jul 2029

Sponsor

Lead sponsor
Azafaros B.V.Industry
Sponsor type
Industry
First posted
Jul 20, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 4 years, up to 30 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A 96-week, open-label, Phase 2 study to evaluate the efficacy and safety of Nizubaglustat (AZ-3102) in patients with Gaucher disease type 3 (GD3).

Conditions

  • Gaucher Disease Type 3

Interventions

  • AZ-3102Drug

    Daily oral intake of AZ-3102 orodispersible tablets

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in hemoglobin levels from BaselineTime frame: 24 weeks
  2. Change in platelet count from BaselineTime frame: 24 weeks
  3. Change in total spleen volume from BaselineTime frame: 24 weeks

Locations

7 sites in 3 countries. Site status is shown where the registry gives one.

  • SMS Medical College Jaipur

    Jaipur, India

  • Maula a Azad medical college Delhi

    New Delhi, India

  • Sir Ganga Ram Hospital

    New Delhi, India

  • University of Child Health Sciences and the Children's Hospital

    Lahore, Pakistan

  • Clininal Trial Unit, Rehman Medical Institute

    Peshawar, Pakistan

  • Gazi University Medical Faculty Hospital

    Yenimahalle, Turkey (Türkiye)

  • Ege Universitesi Tip Fakultesi Hastanesi

    Bornova, İzmir, Turkey (Türkiye)

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.